Late-stage biotech developing therapies for early-stage bladder cancer.
Industry: Health Care
First Day Return: -6.1%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 01/07/2019 |
Offer Price | $11.50 |
Price Range $11.50 - $11.50 | |
Offer Shares (mm) | 2.7 |
Deal Size ($mm) | $31 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 02/12/2019 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $31 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Jerusalem, Israel |
Founded | 2004 |
Employees at IPO | 17 |
Website www.anchiano.com |